|
| Press Releases |
|
 |
|
| Tuesday, October 3, 2023 |
|
|
HanchorBio Announces First Patient Dosed in the Phase 1 Multi-Regional Clinical Trial of HCB101 |
| more info >> |
|
| Monday, August 28, 2023 |
|
|
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies |
| HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies more info >> |
|
|
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies |
| HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies more info >> |
|
| Monday, July 24, 2023 |
|
|
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
| HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the Taiwan Food and Drug Administration (TFDA) has approved its investigational new drug (IND) application to initiate a multi-regional clinical trial of its independently-developed novel drug candidate, HCB101, for the treatment of patients with advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma. more info >> |
|
|
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
| HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the Taiwan Food and Drug Administration (TFDA) has approved its investigational new drug (IND) application to initiate a multi-regional clinical trial of its independently-developed novel drug candidate, HCB101, for the treatment of patients with advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma. more info >> |
|
| Monday, April 17, 2023 |
|
|
HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
| more info >> |
|
|
HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
| HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the US. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to initiate a multi-regional clinical trial of its independently-developed novel drug candidate, HCB101, for the treatment of patients with advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
中創新航發佈盈喜 預期2025全年淨利潤同比大幅上升140%至160% 盈利能力遠超預期
Feb 28, 2026 12:00 HKT/SGT
|
|
|
中创新航发布盈喜 预期2025全年净利润同比大幅上升140%至160% 盈利能力远超预期
Feb 28, 2026 11:55 HKT/SGT
|
|
|
CALB (3931.HK) Announced a Positive Profit Alert
Feb 28, 2026 11:43 HKT/SGT
|
|
|
雲知聲Unisound U1-OCR大模型發布！首個工業級文檔智能基礎大模型，開啟OCR 3.0時代
Feb 28, 2026 09:06 HKT/SGT
|
|
|
Unisound U1-OCR: The First Industrial-Grade Document Intelligence Foundation Model, Ushering in the OCR 3.0 Era
Feb 28, 2026 09:00 HKT/SGT
|
|
|
西普尼(02583.HK)成功納入MSCI全球小型股指數 公司成長潛力再獲印證
Feb 27, 2026 21:03 HKT/SGT
|
|
|
西普尼(02583.HK)成功纳入MSCI全球小型股指数 公司成长潜力再获印证
Feb 27, 2026 21:03 HKT/SGT
|
|
|
NEC Strengthens Multi-Vendor Optical Network Solutions with New TIP-Certified Phoenix Hardware Lineup
Feb 27, 2026 18:50 JST
|
|
|
NEC Demonstrates Agentic AI-Driven Autonomous Network Operations in Collaboration with AWS
Feb 27, 2026 17:31 JST
|
|
|
Mitsubishi Heavy Industries Compressor Acquires Swiss Rotating Equipment Maintenance Company AST Turbo AG
Feb 27, 2026 17:23 JST
|
|
|
三菱重工コンプレッサ、スイスの回転機器メンテナンス工事会社AST Turbo AGを買収
Feb 27, 2026 16:00: JST
|
|
|
天瞳威視IPO觀察：營收結構裡的非共識 - L2量產"養"出L4落地 究竟意味著什麼
Feb 27, 2026 15:42 HKT/SGT
|
|
|
天瞳威视IPO观察：营收结构里的非共识 - L2量产"养"出L4落地 意味着什么
Feb 27, 2026 15:42 HKT/SGT
|
|
|
NEC Strengthens Its Edge Portfolio for the 6G Era, Enabling Efficient Edge Deployment and Integration with Cloud Services
Feb 27, 2026 12:24 JST
|
|
|
Fujitsu POS solution enhances customer experience at Hankyu Hanshin Department Stores
Feb 27, 2026 12:03 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
